BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//London Global Cancer Week - ECPv6.18.4//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:London Global Cancer Week
X-ORIGINAL-URL:https://www.lgcw.org.uk
X-WR-CALDESC:Events for London Global Cancer Week
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Etc/GMT
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20241027T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241113T153000
DTEND;TZID=Etc/GMT:20241113T170000
DTSTAMP:20241112T234348Z
CREATED:20241004T081029Z
LAST-MODIFIED:20241112T234348Z
UID:10000243-1731511800-1731517200@www.lgcw.org.uk
SUMMARY:Impact of climate change in cancer care: experiences around the globe.
DESCRIPTION:Register\nThe webinar aims to increase awareness of the impact of climate change on patients and healthcare professionals;  and highlight ways in which the climate impacts of healthcare can be reduced\, and the role of clinical trials in this endeavour.  This involves discussion of the importance of climate change in cancer care\, testimonies from oncologists of the challenges for patients and providers in climate change impacted areas\, and solution focused talks on sustainability integration into patient care and clinical research. \nRunning Order: \n1. Welcome (Eduardo L. Cazap\, SLACOM) \n2.Introduction about climate change (Joan Schiller\, OUCH-I) \n3. Impact on patients and providers – \na. Experience from Brazil (Gustavo Gossling\, LACOG) \nb. Experience from Nigeria ( Olubukola Ayodele\, University Hospitals of Leicester NHS Trust\, UK ) \nc. Experience from The Philippines (Dr Roselle De Guzman\, Manila Central University-FDT Medical Foundation Hospital) \n4. Tool kits \na. Clinical trials (Lisa Fox\, The Institute of Cancer Research) \nb. Medical Oncology (Seamus O’Reilly\, Cancer Trials Ireland) \nc. Radiotherapy\, (Katie Lichter\, (University of California\, San Francisco\, USA)) \nd. Surgery\, (Shelley Hwang\, Duke University)
URL:https://www.lgcw.org.uk/event/impact-of-climate-change-in-cancer-care-experiences-around-the-globe-2/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2024/10/Logos-together-LGCW-Claire-Hopkins.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241113T150000
DTEND;TZID=Etc/GMT:20241113T160000
DTSTAMP:20241112T234348Z
CREATED:20240807T202815Z
LAST-MODIFIED:20241112T234348Z
UID:10000232-1731510000-1731513600@www.lgcw.org.uk
SUMMARY:Introducing Cardio-Oncology: A Vital Addition for the Cancer Journey
DESCRIPTION:Register\nWith the increasing efficacy of cancer therapies concerns for quality of life continue to grow. Cardiovascular health is recognized as one of the most important areas for patients with cancer and survivors to pay attention to. This session will provide an overview of this developing field including some global perspectives.
URL:https://www.lgcw.org.uk/event/introducing-cardio-oncology-a-vital-addition-for-the-cancer-journey/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2024/08/international-Cardio-Oncology-Society.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241113T143000
DTEND;TZID=Etc/GMT:20241113T153000
DTSTAMP:20250116T232912Z
CREATED:20240708T230552Z
LAST-MODIFIED:20250116T232912Z
UID:10000211-1731508200-1731511800@www.lgcw.org.uk
SUMMARY:Achieving population-based palliative care: Learnings from Telangana\, India
DESCRIPTION:Register\nJoin Drs. Gayatri Palat and Gillian Fyles\, Mr. Swarup Immaraju\, and Ms. Vineela Rapelli as they discuss the road to achieving population-based palliative care in Telangana. \nAccess to effective and affordable palliative and end-of-life care for those with life-limiting diseases\, including cancer\, in lesser–resourced countries is limited\, resulting in a high burden of distress due to pain\, symptoms\, stigma\, isolation\, and financial compromise. \nThis presentation will address how Telangana\, a state in southern India\, moved from an absence of palliative care in the early 2000’s to a current\, internationally recognized palliative care program serving 38 million people in 33 administrative districts. The steps involved in creating this capacity and the key factors underlying successful implementation\, will be presented\, along with a roadmap for implementation that can be replicated elsewhere. We will describe how a collaboration between a state government and Indian and Canadian NGOs resulted in palliative care now being accessible to all\, including in the poorest and the remotest areas of the state.
URL:https://www.lgcw.org.uk/event/achieving-population-based-palliative-care-learnings-from-telangana-india/
LOCATION:Virtual
ATTACH;FMTTYPE=image/jpeg:https://www.lgcw.org.uk/wp-content/uploads/2022/05/two-worlds-banner.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241113T140000
DTEND;TZID=Etc/GMT:20241113T153000
DTSTAMP:20250116T234004Z
CREATED:20240708T230552Z
LAST-MODIFIED:20250116T234004Z
UID:10000210-1731506400-1731511800@www.lgcw.org.uk
SUMMARY:Empowering Young Lives: Exploring the Global Impact\, Benefits\, and Insights of Xploro - An Innovative App Providing Essential Health Information on Childhood Cancer
DESCRIPTION:Register\nThe Xploro app uses gameplay and artificial intelligence to deliver essential health information to young patients and has been proven to strengthen coping mechanisms\, reduce anxiety\, improve procedural experiences and foster better long-term engagement with health services – all of which significantly improve health outcomes. \nThis session will feature a comprehensive demonstration of the Xploro app\, showcasing how it delivers critical health information to young patients in an engaging and accessible way. We will delve into the research underpinning the app’s impact\, highlighting its adaptation for use in low- and middle-income countries where World Child Cancer operates. \nAttendees will also hear firsthand experiences from child life specialists in Ghana and Malawi\, who will discuss the app’s impact on the children and families they support. This event is a unique opportunity to explore how innovative technology can enhance childhood cancer care and support the well-being of young patients globally.
URL:https://www.lgcw.org.uk/event/empowering-young-lives-exploring-the-global-impact-benefits-and-insights-of-xploro-an-innovative-app-providing-essential-health-information-on-childhood-cancer/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2024/07/world-child-cancer-logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241113T120000
DTEND;TZID=Etc/GMT:20241113T130000
DTSTAMP:20241027T123607Z
CREATED:20241021T201403Z
LAST-MODIFIED:20241027T123607Z
UID:10000249-1731499200-1731502800@www.lgcw.org.uk
SUMMARY:“Opportunities in Latin America for improving precision medicine in oncology”
DESCRIPTION:Register \nContext and Rationale \nCancer treatment has seen remarkable progress in recent years\, largely due to the advancements in precision medicine. This innovative approach enables personalized treatments that are tailored to the genetic and molecular characteristics of each patient’s tumor\, revolutionizing the way cancer is treated. With the help of precision diagnostics and genetic testing\, oncologists can now identify specific mutations that drive cancer growth\, paving the way for targeted therapies that are not only more effective but also less toxic than traditional treatments. These breakthroughs have led to significantly improved patient outcomes\, particularly in Europe and the United States\, where health systems have invested heavily in integrating these technologies into standard oncology care. \nIn regions like Europe and the U.S.\, organizations such as ASCO (American Society of Clinical Oncology) and ESMO (European Society for Medical Oncology) have been at the forefront of research and clinical application of precision oncology. Experts in these organizations have helped shape the development and implementation of cutting-edge therapies\, as well as frameworks for precision diagnostics that have set a global benchmark. Their work has provided the foundation for clinical guidelines that support the integration of genetic profiling and biomarker-driven treatments in cancer care. These developments have not only enhanced treatment efficacy but also reduced the economic and physical burden of ineffective therapies. \nHowever\, while these advancements have become more commonplace in Europe and the U.S.\, Latin America faces significant challenges in replicating this progress. There are substantial gaps in infrastructure\, technology\, and funding across the region\, which hinder the adoption of precision medicine. Many countries lack the capacity for widespread genetic testing and molecular diagnostics\, and access to targeted therapies is often limited to a few specialized centers\, creating disparities in care. Additionally\, regulatory frameworks and reimbursement models are not yet fully equipped to support these innovations\, making it difficult for patients to benefit from the full spectrum of precision oncology. \nThis meeting aims to bring together the leading Cancer Institutes of Latin America\, along with key stakeholders and global experts\, to assess the current state of precision medicine in the region. The goal is to diagnose the situational challenges and explore the opportunities for improving cancer care through precision oncology. By drawing on the expertise of professionals involved in ASCO and ESMO\, the meeting will also serve as a platform to share international best practices\, promote collaboration\, and create actionable strategies for overcoming the region’s barriers to innovation. \nMeeting Objectives \n1. Assess the current state of precision medicine and diagnostics in the region: \nReview progress in using molecular diagnostics\, genetic testing\, and the implementation of targeted therapies across different cancer types in Latin America. Identify barriers to accessing these technologies. \n2. Share best practices in genetic testing and targeted therapies: \nFacilitate the exchange of successful experiences in using genetic testing to identify key mutations and selecting appropriate targeted therapies for each patient. \n3. Foster collaboration between cancer institutions: \nExplore cooperation among Cancer Institutes and other organizations to create networks that improve diagnostic capabilities\, share genetic data\, and enhance access to precision therapies. \n4. Develop regional strategies to improve access to precision medicine: \nDiscuss public policies\, funding\, and regulatory frameworks that will help increase the availability of genetic testing and access to targeted therapies \n5. Proposed Agenda Topics \n1. Overview of precision diagnostics and genetic testing in Latin America: \nThe current state of access to advanced molecular diagnostics\, genetic sequencing\, and laboratory capacities across the region. \n2. Advances in targeted therapies (target therapies): \nLatest innovations in the use of targeted therapies and how genetic tests help identify key biomarkers to personalize cancer treatment. \n3. Challenges and barriers to implementing genetic testing and access to precision therapies: \nIdentification of financial\, technological\, and regulatory obstacles that limit the use of genetic testing in clinical practice and access to targeted treatments. \n4. Collaboration and regional networks to enhance access to precision medicine: \nExploration of collaborative models between countries to improve early diagnosis\, data sharing\, and equitable access to targeted therapies. \n5. Public policy to promote precision medicine in oncology: \nProposals for policies that encourage investment in advanced diagnostic technologies and facilitate access to innovative treatments through subsidies\, insurance coverage\, and price regulation. \nExpected Outcomes \n• A current analysis of the state of precision medicine\, genetic testing\, and access to targeted therapies in Latin America. \n• Identification of the main barriers countries face in implementing precision diagnostics and using targeted therapies. \n• Proposals for inter-institutional collaboration to optimize the use of molecular diagnostic technologies and improve accessibility to personalized treatments. \n• Strategic recommendations to improve public policies that promote precision medicine in the region.
URL:https://www.lgcw.org.uk/event/opportunities-in-latin-america-for-improving-precision-medicine-in-oncology/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2024/10/selac-logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241113T120000
DTEND;TZID=Etc/GMT:20241113T130000
DTSTAMP:20250116T234104Z
CREATED:20240708T230552Z
LAST-MODIFIED:20250116T234104Z
UID:10000209-1731499200-1731502800@www.lgcw.org.uk
SUMMARY:Opportunities to prevent liver cancer via urgent acceleration of viral hepatitis elimination
DESCRIPTION:Register\nWith almost a million new cases per year worldwide\, liver cancer is the sixth most common cancer globally\, with the highest rates of new cases and deaths seen in Asia and Africa. With the number of people diagnosed with or dying from liver cancer predicted to rise by 55% by 2040\, liver cancer will place an increasingly heavy burden on health systems across the world. \nThe two major hepatitis viruses—hepatitis B virus and hepatitis C virus—are oncogenic\, and viral hepatitis is a major cause of liver cancer. Despite the availability of an effective vaccine for hepatitis B and a cure for hepatitis C\, efforts to test and treat individuals for viral hepatitis and to prevent these infections are suboptimal. Ramping up these efforts is a critical component of cancer prevention that must be integrated and implemented into cancer prevention efforts globally. \nThe session provides the audience with the opportunity to learn more about the link between viral hepatitis and liver cancer\, and the key challenges facing efforts to eliminate viral hepatitis. The session will also focus on actionable aspects of hepatitis elimination with the end goal of preventing liver cancer.
URL:https://www.lgcw.org.uk/event/preventing-liver-cancer-through-eliminating-viral-hepatitis/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2024/07/Logos-for-LGCW.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241113T110000
DTEND;TZID=Etc/GMT:20241113T120000
DTSTAMP:20241112T234347Z
CREATED:20241017T074508Z
LAST-MODIFIED:20241112T234347Z
UID:10000246-1731495600-1731499200@www.lgcw.org.uk
SUMMARY:Cancer Control through Tobacco Control in East Africa
DESCRIPTION:Register\nIn 2023\, Cancer Research UK and the Union for International Cancer Control launched a joint flagship programme in Kenya and Uganda with the aim of reducing the incidence of preventable cancers through effective tobacco control policies. Join us for this webinar during London Global Cancer Week\, hosted by Cancer Research UK\, to hear directly from Cancer Organisations working to build broad-based Tobacco Tax Coalitions who will be sharing their experiences\, challenges and opportunities in advocating for tobacco control\, and the importance of partnerships and coalition-building in these efforts\, as well as lessons from similar efforts supported by CRUK in in Sri Lanka and Nepal.  \nSpeakers: \nAlex Wright – Head of Global Policy & Programmes\, CRUK \nYannick Romero – Senior Knowledge & Advocacy Manager\, UICC \nPanellists: \nRachel Devotsu – McCabe Centre for Law and Cancer \nPhoebe Ongadi – Kenya Network of Cancer Organisation \nDennis Olodi – Uganda Cancer Society \nOlivia Stevens – KIVU International
URL:https://www.lgcw.org.uk/event/cancer-control-through-tobacco-control-in-east-africa/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2021/11/CRUK-logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241113T093000
DTEND;TZID=Etc/GMT:20241113T110000
DTSTAMP:20241112T234347Z
CREATED:20240708T230552Z
LAST-MODIFIED:20241112T234347Z
UID:10000208-1731490200-1731495600@www.lgcw.org.uk
SUMMARY:Data on ALL\, Hodgkins and Wilms from Partner countries - improvement over time.
DESCRIPTION:Register\nThe Global Child Cancer subgroup of the Children’s Cancer and Leukaemia Group is made up of paediatric oncology doctors\, nurses and allied health professionals. Several paediatric oncology units have links with partner units in developing countries which have been present for many years. At this years London Cancer week we will present survival data on three key tumour types Leukaemia\, Hodgkins disease and Wilms tumour treatment highlighting the improvements that have happened over time. We will then discuss how data collection can be improved and what are the barriers to data collection.
URL:https://www.lgcw.org.uk/event/data-on-all-hodgkins-and-wilms-from-partner-countries-improvement-over-time/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2024/07/CCLG-Logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241113T090000
DTEND;TZID=Etc/GMT:20241113T100000
DTSTAMP:20241109T105455Z
CREATED:20240729T210107Z
LAST-MODIFIED:20241109T105455Z
UID:10000229-1731488400-1731492000@www.lgcw.org.uk
SUMMARY:Oral cancer - causes\, early detection and prevention
DESCRIPTION:Register\nThis upcoming London Global Cancer Week (LGCW) C3 will be joined by Professor Warnakulasuriya – emeritus professor of Oral Medicine and Experimental Pathology at King’s College London – to discuss oral cancer\, it’s causes\, detection and prevention. \nAbout the speaker: \nProfessor Warnakulasuriya is an emeritus professor of Oral Medicine and Experimental Pathology at King’s College London\, UK and was the Chairman of the Oral Medicine Division at King’s College Hospital and at Guy’s Hospital\, London from 2005 -2015. He has made major contributions in cancer epidemiology\, oral medicine and experimental pathology. He is the Director of the WHO Collaborating Centre for Oral Cancer. Professor Warnakulasuriya received the IADR Distinguished Scientist Award in Oral Medicine and Pathology in 2014\, IADR Distinguished Scientist Award in Global Oral Health in 2022. He was elected a Fellow of King’s College London (FKC) for sustained and significant contributions to the College. He holds the Honorary Life Membership of the BSOM and International Association for Oral Pathologists. \nWhy oral cancer: \nOral cancer is the 13th most common cancer worldwide. Despite\, oral cancer being so prevalent and untreated dental caries (tooth decay) being the most common health condition according to the Global Burden of Disease 2019\, oral health is still often overlooked. Oral cancer is largely preventable and shares risk factors with other NCDs\, with tobacco and alcohol among the leading causes. C3 has long recognised the importance of tackling oral diseases including oral cancer through prevention and early detection as part of our mission to address NCDs. In fact\, since 2022 C3 have been working alongside Colgate\, the Commonwealth Nurses and Midwives Federation (CNMF)\, and the World Continuing Education Alliance (WCEA) as part of Colgate Bright Smiles\, Bright Futures\, to raise awareness about the importance of oral health for nurses and midwives and elevate the need for oral health education in practice. Learn more about C3’s oral health programmes.
URL:https://www.lgcw.org.uk/event/the-link-between-oral-health-and-cancer/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2024/07/C3-Collaborating.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241112T200000
DTEND;TZID=Etc/GMT:20241112T220000
DTSTAMP:20241111T234057Z
CREATED:20240729T210105Z
LAST-MODIFIED:20241111T234057Z
UID:10000228-1731441600-1731448800@www.lgcw.org.uk
SUMMARY:Oncology Nursing Now; Where do we stand globally?
DESCRIPTION:Register\nThe Global Power of Oncology Nursing Group (GPON) presents our 2024 annual webinar. Our mission is to provide a global forum for the recognition of the specialty of oncology nursing\, to bridge the gap of disparities in cancer care and share oncology nurses’ experiences\, challenges\, and successes over the past year\, as part of London Global Cancer Week (LGCW). The second virtual session of our 2024 programme is for the West (Americas and Caribbean and early risers in Oceania) and runs from 20.00UTC to 22.30UTC (Mexico City 14:00/Rio de Janeiro 17:00/Sydney 07:00-Wednesday) with simultaneous translation in Spanish. This year we feature speakers and discussants from around the region. Many sub-themes were suggested by GPON members:  \n• Economic Investment in (Oncology) Nursing: a short video from the International Council of Nursing  \n• Empathy/Mindfulness and Self Care in Oncology Nursing: Canadian oncology nurse speaking about an innovative program to address oncology nursing self-care in their hospital  \n• Oncology Nursing Care in Humanitarian Crises: oncology nurse speaker from Palestine \n• Oncology Nurse Research Highlight: an oncology nurse from Peru speaking about quality of life and nursing care of the elderly with cancer in her large cancer hospital in Lima. \n• Inspirational Speaker: a speaker with the lived experience of having had cancer \nIn 2023\, we had 31 speakers and videos from 23 countries and 350 participants from 46 countries. The overwhelming number of nurses caring for patients with cancer are in low- and middle-income countries. As the largest single healthcare workforce\, nurses stand ready to do their share towards care for all and cure for more. GPON highlights and supports the work of all nurses working across the cancer continuum everywhere.
URL:https://www.lgcw.org.uk/event/oncology-nursing-now-where-do-we-stand-globally-2/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2021/05/GPON.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241112T183000
DTEND;TZID=Etc/GMT:20241112T203000
DTSTAMP:20250120T213603Z
CREATED:20240815T144215Z
LAST-MODIFIED:20250120T213603Z
UID:10000234-1731436200-1731443400@www.lgcw.org.uk
SUMMARY:Financing of Global Cancer Care
DESCRIPTION:Register\nHow can we finance global cancer care and treatment? Join us for an evening at The London School of Economics to learn more about the scale of the problem\, how cancer financing works\, innovative solutions to raise funds for cancer care\, and how cancer control systems can be marketed to political leaders.  \nThe talk will feature insightful conversations with expert health economists and health system specialists\, including Dr Rifat Atun (Professor of Global Health Systems at Harvard University)\, Robert Yates (Honorary Associate Professor at the London School of Hygiene and Tropical Medicine)\, Dr Rocco Friebel (Co-Director of the Global Surgery Policy Unit\, LSE) and Dr Martilord Ifeanyichi (Assistant Professorial Research Fellow\, LSE Health).  \nThe discussion will be chaired by Miss Rachel Hargest (Co-Director of the Global Surgery Policy Unit). Participants will interact with panellists during a Q&A session\, fostering a deeper understanding of the financing of cancer care. \nEntry will be free\, and pre-booking is not required for the in-person event at LSE.  If people want to attend online they will need to register on the above website for a link.
URL:https://www.lgcw.org.uk/event/financing-of-global-cancer-care/
LOCATION:London School of Economics\n– room MAR 1.08\, Marshall Building (LSE)
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2024/07/GSPU.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241112T163000
DTEND;TZID=Etc/GMT:20241112T180000
DTSTAMP:20241111T234057Z
CREATED:20240911T215025Z
LAST-MODIFIED:20241111T234057Z
UID:10000242-1731429000-1731434400@www.lgcw.org.uk
SUMMARY:Cancer Moonshot 2.0: win-win collaborations extending the Cancer Moonshot globally leveraging technology/AI
DESCRIPTION:Register\nThe two goals of the Cancer Moonshot are: to reduce the death rate from cancer by at least 50% by 2047\, and improve the experience of people and families living with and surviving cancer\, ultimately ending cancer as we know it today. While the immediate goals are domestic\, the ambitions of the Cancer Moonshot extend far beyond the borders of the United States\, especially as the burden of cancer falls heavily to lower- and middle-income countries\, where 80% of global cancer deaths occur.  \nInternational work as part of the Cancer Moonshot is focused on equity and collaboration\, thereby increasing access to prevention\, screening\, treatment\, and care for everyone facing a cancer diagnosis and their families around the world. This session will cover potential areas for focusing global cancer funding including in particular the use of technology/AI  in win-win collaborations with opportunities to leapfrog in increased access to care across the cancer control continuum while strengthening healthcare systems
URL:https://www.lgcw.org.uk/event/cancer-moonshot-2-0-win-win-collaborations-extending-the-cancer-moonshot-globally-leveraging-technology-ai-2/
LOCATION:Hybrid (In person and virtual)
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2023/05/Global-health-catalyst.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241112T154500
DTEND;TZID=Etc/GMT:20241112T163000
DTSTAMP:20241111T234056Z
CREATED:20240829T172847Z
LAST-MODIFIED:20241111T234056Z
UID:10000240-1731426300-1731429000@www.lgcw.org.uk
SUMMARY:Maximising Cancer Survivorship: The OAC Model for Physical Activity and Holistic Health
DESCRIPTION:Register\nDiscover the profound benefits of Physical Activity & Outdoor Sports as the Cornerstone Pillar (1) and its impact on holistic health\, alongside the other three OAC Key Pillars: (2) Balanced Nutrition\, (3) Sustainability & Nature\, and (4) Physical & Mental Well-being. \nLearn how these four OAC Key Pillars integrate to optimise health\, promote sustainable living\, and nurture overall well-being\, empowering cancer survivors to achieve a vibrant\, balanced\, and sustainable lifestyle. This workshop is tailored for cancer survivors\, advocates\, healthcare professionals\, and academia\, offering actionable insights for enhancing well-being. \nExplore our OAC-Certified Training for Holistic Cancer Support\, where you can learn to tailor exercise programs for cancer patients\, earn certifications (60 CME for Medical Doctors on an international level)\, and contribute to global cancer initiatives. \nPetra Thaller OAC Founder & President \n“We need to ensure that everyone gets the opportunity to rebel for \ntheir own health. What does “Rebel to be Well” mean? I’ve been a rebel all my life. My motto: rules are meant to be broken – for my well-being and that of others. I’ve always brushed aside expectations about what women should or shouldn’t do. Whenever unease crept in\, I rebelled. \nRebellion is a good thing: for independence\, responsibility\, education\, and empowerment. We are in a time of rebellion and should capitalize on it. With my background in Communication Sciences\, Psychology\, and Business (M.Sc.)\, I understand the importance of health literacy. It empowers us to make informed decisions and proactively promote our well-being. “Rebel to be Well” is a call to action. It means questioning conventions and boldly advocating for our health.” \nPh.D. Rūdolf Cešeiko (Riga\, Latvia) is an exercise physiologist and leading specialist at the Exercise Oncology Clinic. \nWith a particular interest in exercise oncology\, his main work is to elucidate research results in aerobic endurance training and neuromuscular force-generating capacity in clinical care. The essential purpose of his research and clinical practice is to identify effective exercise programs for cancer patients and survivors to develop effective tools for prevention\, treatment\, and rehabilitation. \nDr. Tom Degenhardt\, OAC Medical Director and General Practitioner\, Munich\, Germany \n“In private I love being outdoors. As a passionate climber\, skier\, hiker\, paraglider I know about the positive impact on my well-being during and after active time outdoors. Fresh air\, good company and physical activity is my secret recipe for inner motivation and resilience. \nAs a Gynecologist and General Practitioner with a special interest in research and treatment of cancer I am always trying to help patients to improve their quality of life and outcome. Sport is the best evidence based and highly effective supportive therapy without any negative side effects therefore my goal is to motivate all patients to be active. OAC is a great opportunity for patients to meet\, exchange and improve their health status and fitness level in a friendly but professional environment. The combination of profession\, personal interest and high efficacy of physical activity is the basis for my commitment to OAC.​”
URL:https://www.lgcw.org.uk/event/maximising-cancer-survivorship-the-oac-model-for-physical-activity-and-holistic-health/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2024/08/oac-logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241112T150000
DTEND;TZID=Etc/GMT:20241112T154500
DTSTAMP:20241111T234057Z
CREATED:20240829T172847Z
LAST-MODIFIED:20241111T234057Z
UID:10000239-1731423600-1731426300@www.lgcw.org.uk
SUMMARY:WellBeingHER \nA holistic training platform for early breast cancer patients and their caregivers.
DESCRIPTION:Register\nOutdoor Against Cancer (OAC) and Cancer Patients Europe (CPE) are excited to present an innovative project in our upcoming webinar\, which focuses on a comprehensive approach to breast cancer patient care. Our goal is to reach as many participants as possible on a global scale with this significant initiative. \nDespite significant advancements in individualised and highly targeted treatment plans for breast cancer patients\, there remains a notable absence of comprehensive recommendations for various other aspects of patient care including nutrition\, physical activity\, and mental wellbeing. \nRecent research has indicated that incorporating regular physical activity and adopting a well-balanced\, nutrient-dense diet are integral components of comprehensive cancer care that can improve treatment outcomes\, enhance quality of life\, and promote long-term health and well-being for cancer survivors. Yet\, there is little to no guidance\, inadequate resources\, and discouragement on integrating holistic approaches into cancer care. With this project OAC and CPE fill the gap and provide a tailored and holistic wellbeing platform for early breast cancer patients. \nPetra Thaller OAC Founder & President \n“We need to ensure that everyone gets the opportunity to rebel for \ntheir own health.” What does “Rebel to be Well” mean? I’ve been a rebel all my life. My motto: rules are meant to be broken – for my well-being and that of others. I’ve always brushed aside expectations about what women should or shouldn’t do. Whenever unease crept in\, I rebelled. Rebellion is a good thing: for independence\, responsibility\, education\, and empowerment. We are in a time of rebellion and should capitalise on it. With my background in Communication Sciences\, Psychology\, and Business (M.Sc.)\, I understand the importance of health literacy. It empowers us to make informed decisions and proactively promote our well-being. “Rebel to be Well” is a call to action. It means questioning conventions and boldly advocating for our health. \nPh.D. Rūdolf Cešeiko (Riga\, Latvia) is an exercise physiologist and leading specialist at the Exercise Oncology Clinic. With a particular interest in exercise oncology\, his main work is to elucidate research results in aerobic endurance training and neuromuscular force-generating capacity in clinical care. The essential purpose of his research and clinical practice is to identify effective exercise programs for cancer patients and survivors to develop effective tools for prevention\, treatment\, and rehabilitation. \nDr. Tom Degenhardt\, OAC Medical Director and General Practitioner\, Munich\, Germany \n“In private I love being outdoors. As a passionate climber\, skier\, hiker\, paraglider I know about the positive impact on my well-being during and after active time outdoors. Fresh air\, good company and physical activity is my secret recipe for inner motivation and resilience. \nAs a Gynecologist and General Practitioner with a special interest in research and treatment of cancer I am always trying to help patients to improve their quality of life and outcome. Sport is the best evidence based and highly effective supportive therapy without any negative side effects therefore my goal is to motivate all patients to be active. OAC is a great opportunity for patients to meet\, exchange and improve their health status and fitness level in a friendly but professional environment. The combination of profession\, personal interest and high efficacy of physical activity is the basis for my commitment to OAC.​”
URL:https://www.lgcw.org.uk/event/wellbeingher-a-holistic-training-platform-for-early-breast-cancer-patients-and-their-caregivers/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2024/08/oac-logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241112T140000
DTEND;TZID=Etc/GMT:20241112T150000
DTSTAMP:20250119T175807Z
CREATED:20240708T230552Z
LAST-MODIFIED:20250119T175807Z
UID:10000207-1731420000-1731423600@www.lgcw.org.uk
SUMMARY:From Policy to Practice: Transforming Cancer Care in Africa by Implementing Guideline-Concordant Care
DESCRIPTION:Register\nThe panel discussion will explore the critical steps necessary to implement guideline concordant care\, in order to improve cancer outcomes in Africa. There are contextual barriers to delivering quality cancer treatment\, including limited resources\, insufficient healthcare infrastructure\, and disparities in access to care. This session will bring together leading experts\, policymakers\, and cancer care providers to discuss strategies for translating national cancer control plans (NCCP) into guideline-concordant care that aligns with international quality of care standards. \nKey topics will include the development and dissemination of NCCPs tailored to the African context\, innovative approaches to training healthcare professionals and embedding a culture of quality improvement in care delivery. Furthermore\, the session will explore the integration of culturally-tailored\, palliative care and symptom management along the entire cancer care continuum. Finally\, this session will highlight successful case studies from specific African countries where policy changes have led to tangible improvements in clinical practice and patient outcomes. \nParticipants will gain insights into effective collaboration between ministries of health\, non-governmental organizations\, and the private sector. Additionally\, the discussion will address the importance of community engagement and patient advocacy in driving systemic change. By the end of the session\, attendees will have a clearer understanding of the practical steps needed to translate NCCPs into practice\, ultimately aiming to reduce cancer mortality rates in Africa through guideline-concordant care delivery.
URL:https://www.lgcw.org.uk/event/from-policy-to-practice-transforming-cancer-care-in-africa-by-implementing-guideline-concordant-care/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2024/07/University-of-Pennsylvania.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241112T133000
DTEND;TZID=Etc/GMT:20241112T150000
DTSTAMP:20241111T234056Z
CREATED:20240729T210103Z
LAST-MODIFIED:20241111T234056Z
UID:10000227-1731418200-1731423600@www.lgcw.org.uk
SUMMARY:The Lancet Oncology Commission on Radiotherapy and Theranostics
DESCRIPTION:Register\nFollowing on from The Lancet Oncology Commission on Expanding Global Access to Radiotherapy\, The Lancet Oncology Commission on Radiotherapy and Theranostics aims to assess the current status of access and availability of radiotherapy and address the important issue of access to the promising field of theranostics at a global level. A marked disparity in the availability of radiotherapy machines between high-income and low-income and middle-income countries (LMICs) was previously identified and remains a major problem. Access and availability of radiopharmaceuticals is impacting on theranostics use in many high-income countries and LMICs. The availability of a suitably trained and credentialled workforce has also been highlighted as a major limiting factor in effective implementation of radiotherapy\, and theranostics\, particularly in LMICs. \nIn this Lancet Webinar\, authors of The Lancet Oncology Commission will discuss action points and investment that could enhance access to radiotherapy and theranostics\, particularly in LMICs\, to realise health and economic benefits and reduce the global burden of cancer by increasing access to these essential treatments
URL:https://www.lgcw.org.uk/event/the-lancet-oncology-commission-on-radiotherapy-and-theranostics/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2021/05/lancet-logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241112T130000
DTEND;TZID=Etc/GMT:20241112T140000
DTSTAMP:20241111T234056Z
CREATED:20240708T230552Z
LAST-MODIFIED:20241111T234056Z
UID:10000204-1731416400-1731420000@www.lgcw.org.uk
SUMMARY:Defining opportunities to improve survival and quality of life for women in low- and middle-income countries through the Every Woman Study.  Could the findings of an ovarian cancer patient experience study benefit the wider community?
DESCRIPTION:Register\nWith data gathered from almost 2\,500 women with ovarian cancer from 22 low- and middle-income countries\, join us for an overview of the study and results\, country leads\, and commentary from three global oncology leaders committed to transformational change. The event will be a mix of presentation\, videos and live discussion.
URL:https://www.lgcw.org.uk/event/defining-opportunities-to-improve-survival-and-quality-of-life-for-women-in-low-and-middle-income-countries-through-the-every-woman-study-could-the-findings-of-an-ovarian-cancer-patient-experience-3/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2024/07/ovariancancer.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241112T120000
DTEND;TZID=Etc/GMT:20241112T130000
DTSTAMP:20250126T165438Z
CREATED:20240807T202814Z
LAST-MODIFIED:20250126T165438Z
UID:10000231-1731412800-1731416400@www.lgcw.org.uk
SUMMARY:World-wide trends in patterns of care for breast\, cervical and ovarian cancers – The VENUSCANCER project
DESCRIPTION:Watch here\nThe CONCORD programme documented wide global differences in survival trends\, still persistent in 2010-2014\, for women diagnosed with breast cancer (66% in India; over 90% in the US and Australia)\, cervical (52% in Ecuador; 77% in Korea) or ovarian (16% in India; 57% in Costa Rica) cancers. \nThe VENUSCANCER project\, embedded in the CONCORD programme\, examines whether global differences in survival are attributable to differences in disease biology between populations\, or patterns of care\, or socio-economic status. \nCancer registries were invited to submit data for a single year of complete incidence during 2015-2018\, for which availability and completeness of high-resolution variables (e.g.\, stage\, staging procedures\, biomarkers\, treatment) were highest. VENUSCANCER offered financial support to 11 registries in low- and middle-income countries to enable collection of these data.  \nDuring this webinar we will discuss the world-wide adherence to international clinical guidelines for cervical and ovarian cancer.
URL:https://www.lgcw.org.uk/event/world-wide-trends-in-patterns-of-care-for-breast-cervical-and-ovarian-cancers-the-venuscancer-project/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2023/05/erc-logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241112T110000
DTEND;TZID=Etc/GMT:20241112T130000
DTSTAMP:20241030T130357Z
CREATED:20240717T071141Z
LAST-MODIFIED:20241030T130357Z
UID:10000222-1731409200-1731416400@www.lgcw.org.uk
SUMMARY:Risk reduction Strategies in Cancer Prevention
DESCRIPTION:Register\nThis session will discuss risk reduction strategies and harm mitigation in cancer prevention. \nThe topics will include matters such as the need for these types of actions and reasons for the failure of previous strategies\, together with some language definitions. \nSpeakers will also present different fields of application and how to implement reduction measures in practice. Some examples will be presented in obesity and smoking control. \nAGENDA \n“Risk reduction Strategies in Cancer Prevention” \n11:00 – 11:15 – Welcome and introductions: Dr. Eduardo Cazap (Arg) \n11:15 – 11:45 – Key Note Conference “ Looking to the Future”   Prof. Bob Pinedo ( The Neetherlands) (TBC) \n11:45 – 12:15 – Risk Reduction: is it needed? Prof. David Khayat (France) \n12:15 – 12:45 – Risk Reduction in practice: Dr. Peter Harper (UK) \n12:45 – 13:00 – Discussion (All)
URL:https://www.lgcw.org.uk/event/risk-reduction-strategies-in-cancer-prevention/
LOCATION:Hybrid (In person and virtual)
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2023/05/slacom-logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241112T070000
DTEND;TZID=Etc/GMT:20241112T110000
DTSTAMP:20241111T234056Z
CREATED:20240726T073741Z
LAST-MODIFIED:20241111T234056Z
UID:10000226-1731394800-1731409200@www.lgcw.org.uk
SUMMARY:Oncology Nursing Now; Where do we stand globally?
DESCRIPTION:Register\nThe Global Power of Oncology Nursing Group (GPON) presents our 2024 annual webinar. Our mission is to provide a global forum for the recognition of the specialty of oncology nursing\, to bridge the gap of disparities in cancer care and share oncology nurses’ experiences\, challenges\, and successes over the past year\, as part of London Global Cancer Week (LGCW).  \nOur programme for 2024 runs in two sessions – Tuesday 12th November early morning UK time is Part 1) 07.00 UTC – 11.00 UTC for the Eastern hemisphere (i.e. Europe\, Africa and east to Oceania)\, followed by the West session\, late evening UK time.  \nThis year we plan to feature the following subthemes featuring speakers and discussants from around the world including resource-constrained settings.  Many of these subthemes were suggested by GPON members: \n•Economic Investment in (Oncology) Nursing  \n•Empathy/Mindfulness and Self Care in Oncology Nursing \n•Oncology Nursing Care in Humanitarian Crises \n•Oncology Nurse Research Highlight \n•Inspirational Speaker: An African this year\, now living in the UK with  Lived Experience of Cancer  \nIn 2023\, we had 31 speakers and videos from 23 countries and a total of 350 participants from 46 countries. This year\, we want to go even further. \nThe conferences (East and West in the evening) showcase the contributions and expertise of oncology nurses in tackling the burden of cancer across the continuum from screening to end-of-life care or survivorship through engaging stories\, discussion\, and presentations by colleagues from around the world. Most oncology nurse presenters are from LMICs. As the largest single healthcare workforce\, nurses stand ready to do their share towards a care/cure for all\, and GPON highlights and supports their ongoing work in this direction.
URL:https://www.lgcw.org.uk/event/oncology-nursing-now-where-do-we-stand-globally/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2021/05/GPON.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241111T150000
DTEND;TZID=Etc/GMT:20241111T163000
DTSTAMP:20250119T180958Z
CREATED:20240812T203215Z
LAST-MODIFIED:20250119T180958Z
UID:10000233-1731337200-1731342600@www.lgcw.org.uk
SUMMARY:Prioritizing cancer screening and early diagnosis in the EMR
DESCRIPTION:Register\nThe majority of cancer patients in the Eastern Mediterranean Region (EMR) are diagnosed in the late stages\, which increases treatment costs and resources\, and compromises health outcomes and survival rates. Directing healthcare spending towards screening should be an immediate policy priority because it will help support early diagnosis\, thereby lowering treatment costs\, while reducing the cancer mortality rate.
URL:https://www.lgcw.org.uk/event/prioritizing-cancer-screening-and-early-diagnosis-in-the-emr/
LOCATION:Virtual
ATTACH;FMTTYPE=image/jpeg:https://www.lgcw.org.uk/wp-content/uploads/2022/08/EMNCDA-Logo-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241111T140000
DTEND;TZID=Etc/GMT:20241111T170000
DTSTAMP:20241110T234110Z
CREATED:20240708T230552Z
LAST-MODIFIED:20241110T234110Z
UID:10000201-1731333600-1731344400@www.lgcw.org.uk
SUMMARY:Putting the older patients first
DESCRIPTION:Register\nOver two-thirds of deaths in the world are from cancer and around half are in patients >70 years.  Possible factors include the increase in population and the fact that cancer is a disease of ageing.  However\, both globally and in the UK\, we do not appear to have an integrated approach to care for older people with cancers.  This session will look at the challenges and opportunities on how we could do better\, from the perspectives of both the healthcare professional and the patient.
URL:https://www.lgcw.org.uk/event/putting-the-older-patients-first/
LOCATION:Hybrid (In person and virtual)
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2024/07/siog.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241111T140000
DTEND;TZID=Etc/GMT:20241111T153000
DTSTAMP:20250815T213916Z
CREATED:20241018T174636Z
LAST-MODIFIED:20250815T213916Z
UID:10000247-1731333600-1731339000@www.lgcw.org.uk
SUMMARY:Cancer and Conflict in Africa:  a spotlight on the Sahel
DESCRIPTION:Register\nThe Sahel region in Africa stretches from Senegal and Gambia on the Atlantic coast through Mali\, Mauritania\, Burkina Faso\, Nigeria\, Niger\, Chad\, and Sudan to the northwestern part of Ethiopia and Eritrea on the Red Sea coast. Many of the 16 African countries in conflict are contiguous\, stretching from the western Sahel through the Horn of Africa\, encompassing the Lake Chad Basin and Great Lakes regions.    \nClimate change\, conflict and political instability have resulted in the biggest humanitarian crises in the world\, severely disrupting healthcare. The cancer care needs of conflict- affected populations continues to be a low priority in international and continental responses to the crises in the Sahel.  In this session we will be shining a light on cancer care in the Sahel\, hearing from those practising in these countries and other stakeholders about what the future holds for the Region.
URL:https://www.lgcw.org.uk/event/cancer-and-conflict-in-africa-a-spotlight-on-the-sahel/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2022/06/Aortic-logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241111T140000
DTEND;TZID=Etc/GMT:20241111T150000
DTSTAMP:20250116T233905Z
CREATED:20240708T230552Z
LAST-MODIFIED:20250116T233905Z
UID:10000202-1731333600-1731337200@www.lgcw.org.uk
SUMMARY:Progress in childhood cancer data sharing to inform policy and accelerate care and research
DESCRIPTION:Register\nImproving outcomes for children and young people with cancer requires extensive multi-faceted knowledge of clinical factors\, tumour biology\, therapeutic approaches and the health care system in which these are delivered. New approaches to data integration/linkage and analysis are now possible\, to accelerate understanding of these rare and heterogeneous cancers and the factors that influence survival and morbidity. \nThis session aims to showcase recent initiatives to harness the power of collecting and comparing data at a large scale. Examples will be given of the importance of standardised data for international comparisons and analysis of future trends. Ways to achieve more equitable\, locally-informed cancer intelligence for national cancer control planning will be discussed. The ambition is to achieve global reach and show how data can support implementation of the WHO Global Initiative for Childhood Cancer.
URL:https://www.lgcw.org.uk/event/progress-in-childhood-cancer-data-sharing-to-inform-policy-and-accelerate-care-and-research/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2021/05/siop-logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241111T130000
DTEND;TZID=Etc/GMT:20241111T140000
DTSTAMP:20250116T233445Z
CREATED:20240708T230552Z
LAST-MODIFIED:20250116T233445Z
UID:10000203-1731330000-1731333600@www.lgcw.org.uk
SUMMARY:Bridging medicine and emotional support in cancer therapy
DESCRIPTION:Register\nThe Children’s Cancer Center of Lebanon\, in collaboration with the wellness instructors\, CCCL team members\, survivors\, partners\, and national NGOs\, will host a groundbreaking virtual dialog discussing the importance of the cancer patient’s wellbeing and mental health. The session intends to allow the attendees to learn more about the benefits of having a comprehensive treatment that combines the medical and the mental well-being of cancer patients. The session will provide the speakers a platform to discuss their work\, experiences and most importantly feelings and emotions. They will be sharing happy and sometimes sad stories they encountered\, testimonials\, and benefits of a fully integrated therapy of care for patients everywhere. \nThis session will permit panelists and attendees to share their personal stories\, highlighting the physical\, emotional\, and social challenges\, and to provide valuable insights into the holistic needs of every cancer patient. It will promote and emphasize the importance of expressing emotions and feelings\, especially during treatment\, and highlight the significance of building partnerships that support patients and their families. The session aims to foster dialogue among panelists with unique approaches to the psychosocial aspects of patient care and call on national NGOs to integrate psychosocial activities into their support and care for cancer patients.
URL:https://www.lgcw.org.uk/event/bridging-medicine-and-emotional-support-in-cancer-therapy/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2023/05/CCCL.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241111T113000
DTEND;TZID=Etc/GMT:20241111T123000
DTSTAMP:20241110T234109Z
CREATED:20240708T230552Z
LAST-MODIFIED:20241110T234109Z
UID:10000200-1731324600-1731328200@www.lgcw.org.uk
SUMMARY:Pediatrician focussed initiatives to improving childhood cancer outcome
DESCRIPTION:Register\nWe stand around half a decade away from the WHO’s goal of achieving 60% survival for pediatric cancers. The diversity in healthcare services globally is vivid and WHO still describes childhood cancer as a disease where outcome depends on where you are born. \nAs health professionals involved in the childhood cancer care\, we have worked to understand the “why” behind disparities in outcome. Many of these are being addressed through capacity building\, collaborative research and advocacy.  \nA major reason why children are not diagnosed or referred timely is because they are not recognized by the primary care pediatricians. The eye sees only what the mind knows. The curriculum for pediatricians which is dedicated to hematology/oncology varies widely between countries. Often only a fraction of this gets taught in medical schools due to poor local resources. Thus\, efforts directed at standardizing and strengthening the knowledge-base of trainees would help immensely in early referrals and in shared care.  \nAt the LGCW this year\, we propose to highlight national pediatric society / professional society led initiatives focussed on pediatricians to improve their awareness and capacity to diagnose cancer early\, stabilise children with standard of care and to refer early\, thus contributing to better outcomes.
URL:https://www.lgcw.org.uk/event/pediatrician-focussed-initiatives-to-improving-childhood-cancer-outcome/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2024/07/IPA-Logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241111T100000
DTEND;TZID=Etc/GMT:20241111T123000
DTSTAMP:20250116T234301Z
CREATED:20240726T073741Z
LAST-MODIFIED:20250116T234301Z
UID:10000225-1731319200-1731328200@www.lgcw.org.uk
SUMMARY:The global cancer workforce in crisis: how to reverse a threatening trend\, build capacities and promote equity
DESCRIPTION:Register\nThe World Health Organization\, International Atomic Energy Agency and International Agency for Research on Cancer are pleased to host a 2.5-hour interactive session presenting trends in the cancer workforce globally\, understanding current and future challenges and discussing pro-equity\, evidence-based\, approaches to build national capacities and organize a global response. This session will feature activities from partners mobilizing communities and gathering data\, from national cancer programme managers delivering local solutions and from UN agencies implementing country-tailored approaches to this global challenge. \nEvent page
URL:https://www.lgcw.org.uk/event/the-global-cancer-workforce-in-crisis-how-to-reverse-a-threatening-trend-build-capacities-and-promote-equity/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2024/07/WHO-IAEA.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241111T083000
DTEND;TZID=Etc/GMT:20241111T100000
DTSTAMP:20250120T221707Z
CREATED:20240802T160317Z
LAST-MODIFIED:20250120T221707Z
UID:10000230-1731313800-1731319200@www.lgcw.org.uk
SUMMARY:2024 London Global Cancer Week (LGCW) -- China-UK Anti-Cancer Summit
DESCRIPTION:Register\nCancer is one of the leading causes of illness and death in the world. As the population ages\, the global burden of cancer will continue to increase. It is expected that the total number of cancer patients worldwide will reach approximately 28 million by 2040\, and there will be 16.2 million deaths. Over 40% of cancer cases are attributed to preventable factors\, such as smoking\, unhealthy diet\, and lack of exercise. Basic research and innovative therapies are also changing patients’ outcome. The future path to fighting against cancer requires international cooperation and the promotion of scientific and technological innovation. \nThe “2024 London Global Cancer Week (LGCW) — China-UK Anti-Cancer Summit” is organized by China Anti-Cancer Association (CACA) and London Global Cancer Week (LGCW). The language of this event will be English with Chinese simultaneous translation. The event will invite anti-cancer leaders from CACA and LGCW to jointly explore basic research\, share the latest achievements in clinical practice\, and exchange ideas and perspectives on the treatment of cancer patients.
URL:https://www.lgcw.org.uk/event/2024-london-global-cancer-week-lgcw-china-uk-anti-cancer-summit/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2024/08/lgcw-caca-logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20231117T180000
DTEND;TZID=Europe/London:20231117T190000
DTSTAMP:20231128T213612Z
CREATED:20231024T171205Z
LAST-MODIFIED:20231128T213612Z
UID:10000187-1700244000-1700247600@www.lgcw.org.uk
SUMMARY:Texas Children’s Global HOPE discussion on pediatric cancer in sub-Saharan Africa
DESCRIPTION:Register Here!Texas Children’s Global HOPE discussion on pediatric cancer in sub-Saharan Africa  Friday\, November 17th from 1-2pm ET / 6-7pm London time \nHosted by: Texas Children’s Global HOPE \nAfrica is facing a childhood cancer crisis. At present\, 90% of the over 100\,000 cases that occur each year die. It has been stated that Africa is facing a “childhood cancer tsunami” in that\, by 2050\, half of the world’s childhood cancer cases will be located in sub-Saharan Africa! Global HOPE\, a capacity building program of Texas Children’s Hospital and Baylor College of Medicine\, is training African doctors\, nurses and other healthcare professionals to effectively treat children with cancer. Since its’ inception six and a half years ago\, Global HOPE has trained 33 pediatric oncologists\, over 700 nurses and more than 5000 other healthcare workers treating thousands of children with cancer in 6 African countries\, significantly improving survival. Clearly\, much larger initiatives\, including many cross-sector partners are needed to address the oncoming childhood cancer tsunami. Global HOPE is hosting an expert panel comprised of leaders from nonprofits\, government\, and the private sector to discuss strategic approaches to address this extraordinary challenge.  \nSpeakers include:  \n\nDr. David Poplack\, Director\, Global HOPE\nDr. Joseph Lubega\, Deputy Director\, Global HOPE\nDr. Marilyn Hockenberry\, Director of Global HOPE Nursing\,  Global HOPE \nAmadou Diarra\, Senior Vice President\, Global Policy\, Advocacy\, and Government Affairs\, Bristol Myers Squibb \nTom Tighe\, President and CEO of Direct Relief
URL:https://www.lgcw.org.uk/event/texas-childrens-global-hope-discussion-on-pediatric-cancer-in-sub-saharan-africa/
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2023/10/texas-childrens.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20231117T090000
DTEND;TZID=Europe/London:20231117T180000
DTSTAMP:20231117T174159Z
CREATED:20230522T213408Z
LAST-MODIFIED:20231117T174159Z
UID:10000138-1700211600-1700244000@www.lgcw.org.uk
SUMMARY:Global cancer control: bridging boundaries
DESCRIPTION:LIVE IN PERSON EVENTRegister Here  \nGlobal cancer control: Bridging boundaries\nFri 17 November @ 09:00 am – 6:00 pm  GMT Hosted by: Royal Society of Medicine Oncology Group \nJoin us for this engaging and informative meeting\, as part of the London Global Cancer Week\, to hear from a delegation of international experts who will speak about global disparities in cancer care and control and present various strategies to improve cancer outcomes. These strategies will cover the cancer care continuum from prevention\, screening\, early diagnosis and treatment to palliative care and survivorship. The meeting will also cover several topics\, such as the role of women\, communication\, education\, intelligence gathering and technology in cancer care.  \nBy attending\, you will also hear from those working on novel and innovative ways to change current inequalities and inequities to enable capacity building in LMICs. Issues such as the financial toxicity of cancer care will be discussed\, and the “Choosing Wisely” and “Common Sense in Oncology” movements will be highlighted. \n  \nBy attending\, you will: \n\nLearn about current examples of good practice in cancer care across six continents\nLearn about future ways of improving cancer outcomes globally through the use of technology and scientific advances \nHear from leading experts about global disparities in cancer care and control  \nDrive north-south and south-south collaborations to close the cancer care gap  \nUnderstand financial toxicity of cancer care  \nlearn about the Common Sense in Oncology and Choosing Wisely movements in cancer care to optimise limited resources \n\nRegistration is now open! \nFor more information\, including agenda and speakers\, please click here 
URL:https://www.lgcw.org.uk/event/royal-society-of-medicine-oncology-group-all-day-event/
LOCATION:The Royal Society of Medicine\, 1 Wimpole Street\, Marylebone High Street\, United Kingdom
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2021/05/RSM-logo.png
GEO:51.5156526;-0.1470953
X-APPLE-STRUCTURED-LOCATION;VALUE=URI;X-ADDRESS=The Royal Society of Medicine 1 Wimpole Street Marylebone High Street United Kingdom;X-APPLE-RADIUS=500;X-TITLE=1 Wimpole Street:geo:-0.1470953,51.5156526
END:VEVENT
END:VCALENDAR